Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Allergy to glycopyrronium |
Causative agent (attribute) |
True |
Glycopyrronium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Glycopyrrolate |
Is modification of (attribute) |
True |
Glycopyrronium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Glycopyrronium adverse reaction |
Causative agent (attribute) |
True |
Glycopyrronium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing glycopyrronium in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glycopyrronium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Glycopyrronium- and neostigmine-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glycopyrronium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing glycopyrronium in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glycopyrronium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing glycopyrronium in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glycopyrronium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Glycopyrronium- and neostigmine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glycopyrronium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing glycopyrronium (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glycopyrronium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Glycopyrronium only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glycopyrronium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only glycopyrronium and neostigmine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glycopyrronium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Glycopyrronium and neostigmine only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glycopyrronium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Glycopyrronium only product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glycopyrronium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Glycopyrronium only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glycopyrronium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Glycopyrronium only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glycopyrronium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely glycopyrronium (as glycopyrronium bromide) 320 microgram/1 milliliter conventional release oral solution (clinical drug) |
Has basis of strength substance (attribute) |
True |
Glycopyrronium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely glycopyrronium (as glycopyrronium bromide) 160 microgram/1 milliliter conventional release oral solution (clinical drug) |
Has basis of strength substance (attribute) |
True |
Glycopyrronium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Glycopyrronium (as glycopyrronium bromide) 44 microgram/actuation powder for inhalation |
Has basis of strength substance (attribute) |
True |
Glycopyrronium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only glycopyrronium in pulmonary dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glycopyrronium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing glycopyrronium in pulmonary dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glycopyrronium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |